Search results for "Vaccination."

showing 10 items of 654 documents

Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.

2013

Contribution over time of human papillomavirus (HPV) types in human cancers has been poorly documented. Such data is fundamental to measure current HPV vaccines impact in the years to come. We estimated the HPV type-specific distribution in a large international series of invasive cervical cancer (ICC) over 70 years prior to vaccination. Paraffin embedded ICC cases diagnosed between 1940 and 2007 were retrieved from eleven countries in Central-South America, Asia and Europe. Included countries reported to have low-medium cervical cancer screening uptake. Information on age at and year of diagnosis was collected from medical records. After histological confirmation, HPV DNA detection was per…

OncologyAdultCancer ResearchInvasive cervical cancermedicine.medical_specialtyAsiavirusesUterine Cervical NeoplasmsHPV vaccinesLogistic regressionInternal medicinemedicineHumansNeoplasm InvasivenessHuman papillomavirusEarly Detection of CancerAgedRetrospective StudiesGynecologyCervical cancerHuman papillomavirus 16Paraffin EmbeddingHuman papillomavirus 18business.industryTime trendsMedical recordvirus diseasesCentral AmericaMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsVaccinationEuropeLogistic ModelsOncologyDNA ViralFemalebusinessInternational journal of cancer
researchProduct

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

2023

AbstractThe long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has been little explored. A prospective multicenter registry-based cohort study conducted from December 2020 to July 2022 by the Spanish Transplant and Cell Therapy group, was used to analyze the relationship of antibody response over time after full vaccination (at 3–6 weeks, 3, 6 and 12 months) (2 doses) and of booster doses with breakthrough SARS-CoV-2 infection in 1551 patients with hematological disorders. At a median follow-up of 388 days after complete immunization, 266 out of 1551 (17%) developed breakthrough SARS-CoV-2 infection a…

OncologySARS-CoV-2VaccinationCOVID-19Malalties transmissiblesVacunacióHematologyHematologia
researchProduct

T-Zelltherapien in der Onkologie

2002

OncologyTransplantationVaccinationmedicine.medical_specialtymedicine.anatomical_structurebusiness.industryInternal medicineT cellmedicineGeneral MedicineStem cellbusinessAllogeneic transfusionDMW - Deutsche Medizinische Wochenschrift
researchProduct

CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy

2019

The 17th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe`s cancer immunotherapy meeting, took place in Mainz, Germany from 21 to 23 May, 2019. Recent advancements in cance...

Oncologymedicine.medical_specialtyCombination therapymedicine.medical_treatment030231 tropical medicineImmunologyMeeting ReportCancer Vaccinescombination therapyCell therapy03 medical and health sciences0302 clinical medicineCancer immunotherapyNeoplasmsInternal medicineTumor MicroenvironmentHumansImmunology and AllergyMedicine030212 general & internal medicinetumor vaccinationPersonalized therapypersonalized therapyPharmacologyTumor microenvironmentcancer immunotherapybusiness.industryCIMTcellular therapyCongresses as Topiccheckpoint blockadeImmunotherapybusinessHuman Vaccines & Immunotherapeutics
researchProduct

SARS‐CoV ‐2‐reactive antibody detection after SARS‐CoV ‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the S…

2021

This is a multicenter prospective observational study which included a large cohort (n = 397) of allogeneic (allo-HSCT) (n = 311) and autologous (ASCT) hematopoietic stem cell transplant (n = 86) recipients who were monitored for antibody detection within 3 to 6 weeks after complete SARS-CoV-2 vaccination from February 1st 2021 to July 20th 2021. Most patients (n = 387, 97.4%) received mRNA-based vaccines. Most of recipients (93%) were vaccinated more than 1 year after transplant. Detectable SARS-CoV-2-reactive antibodies were observed in 242 (78%) of allo-HSCT and in 73 (85%) of ASCT recipients. Multivariate analysis in allo-HSCT recipients identified lymphopenia <1x109 /mL [Odds ratio (OR…

Oncologymedicine.medical_specialtybiologybusiness.industrymedicine.medical_treatmentHematopoietic stem cellHematologyDiseaseOdds ratioHematopoietic stem cell transplantationmedicine.diseaseLymphomaCell therapyVaccinationmedicine.anatomical_structureInternal medicinemedicinebiology.proteinAntibodybusinessAmerican Journal of Hematology
researchProduct

Systematic review and meta-analysis of determinants associated with HPV vaccination uptake in Europe

2020

Abstract Background Human papillomavirus (HPV) vaccines are the most important strategy to prevent HPV-related cancers and benign lesions. However, low immunization levels observed in several countries requires a deeper analysis of determinants associated with HPV vaccination uptake. Aim of the research is to identify the main determinants associated with HPV vaccination uptake among European adolescents, through a systematic literature review and meta-analysis. Methods The research was conducted on electronic databases including PubMed/MEDLINE and SCOPUS, identifying 1147 studies. Original articles published between 2000 and 2018 were retrieved, with restriction criteria applied to the Eur…

Oncologymedicine.medical_specialtybusiness.industryMeta-analysisInternal medicinePublic Health Environmental and Occupational HealthmedicineHpv vaccinationbusinessEuropean Journal of Public Health
researchProduct

BCR-ABL Derived Peptide Vaccine in Chronic Myeloid Leukemia Patients with Molecular Minimal Residual Disease During Imatinib: Interim Analysis of a P…

2009

Abstract Abstract 648 Introduction: Imatinib (IM) 400mg daily is the standard treatment for chronic myeloid leukemia (CML) patients and a complete cytogenetic response (CCyR) is achieved in the majority of patients within one year of treatment. In addition, a considerable number of patients reach a major molecular response (i.e BCR-ABL/ABL ratio &lt;0.1%) but BCR-ABL transcript is still measurable in most of treated patients revealing the persistence of a minimal residual disease (MRD). In a previous small pilot study, vaccinations with p210 b3a2-derived fusion peptides in IM treated CML patients appeared to induce both a peptide specific immune response and a reduction of residual disease …

Oncologymedicine.medical_specialtybusiness.industrySurrogate endpointStandard treatmentImmunologyMyeloid leukemiaAlpha interferonImatinibCell BiologyHematologyInterim analysisBiochemistryMinimal residual diseaseVaccinationhemic and lymphatic diseasesInternal medicineImmunologymedicinebusinessmedicine.drug
researchProduct

Pandemia e vaccinazione dei lavoratori nello scenario comparato

2022

The essay analyses Covid-19 workers’ vaccinations in the Italian, Spanish, French, and US legal frameworks. By using the function of cultural orientation of comparative method, the work highlights that in Southern-Europe workers’ vaccination may be mandated by the legislator with the aim to promote collective health. By the contrary the US system, centred on the freedom of economic initiative, allows employer-mandated vaccinations in lack of specific legislation. Il saggio analizza in chiave comparata la vaccinazione del lavoratore contro il virus Sars-Covid 19 negli ordinamenti italiano, spagnolo, francese e statunitense. Nel privilegiare la funzione di orientamento culturale della compara…

Pandemic mandated vaccination workers Italy France Spain USSettore IUS/07 - Diritto Del LavoroPandemia vaccinazione obbligatoria lavoratori Italia Francia Spagna USA
researchProduct

Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-anal…

2016

ABSTRACT Low measles, mumps and rubella (MMR) immunization levels in European children highlight the importance of identifying determinants of parental vaccine uptake to implement policies for increasing vaccine compliance. The aim of this paper is to identify the main factors associated with partial and full MMR vaccination uptake in European parents, and combine the different studies to obtain overall quantitative measures. This activity is included within the ESCULAPIO project, funded by the Italian Ministry of Health. ORs and CIs were extracted, sources of heterogeneity explored and publication bias assessed. Forty-five papers were retrieved for the qualitative study, 26 of which were i…

ParentsHealth Knowledge Attitudes PracticePediatricsmedicine.medical_specialtyMeasles-Mumps-Rubella Vaccinedeterminant; measles; mumps and rubella; parents; uptake; vaccine; Immunology and Allergy; Immunology; PharmacologyImmunologyReviewdeterminantSettore MED/42 - Igiene Generale E ApplicataMMR vaccineRubellaMeasles03 medical and health sciences0302 clinical medicinevaccine030225 pediatricsHumansmeaslesmeasleImmunology and AllergyMedicinemumps and rubella030212 general & internal medicineMumpsRubellaPharmacologyPracticebusiness.industryHealth KnowledgeVaccinationPublication biasPatient Acceptance of Health Caremedicine.diseaseEuropeVaccinationparentdeterminant; measles; mumps and rubella; parents; uptake; vaccine; Europe; Health Knowledge Attitudes Practice; Humans; Measles; Measles-Mumps-Rubella Vaccine; Mumps; Patient Acceptance of Health Care; Rubella; Vaccination; ParentsAttitudesuptakeMeta-analysisMarital statusbusinessMeasles-Mumps-Rubella VaccineDemographyHuman Vaccines &amp; Immunotherapeutics
researchProduct

Post vaccine acute disseminated encephalomyelitis as the first manifestation of chromosome 22q11.2 deletion syndrome in a 15-month old baby: a case r…

2014

We describe a case of a 15-month-old female child admitted to our hospital because of fever, rash, neurological signs (oscillation between states of irritability and drowsiness), palpebral edema and drooping eyelid, appeared 10 days after the vaccination for measles, mumps and rubella. Brain MRI images showed multiple bilateral hyperintense lesions in the white matter typical of acute disseminated encephalomyelitis (ADEM), an autoimmune demyelinating disorder with inflammatory lesions of the central nervous system, due to viral antigens or vaccines. In the mean time, because of patient's vague phenotypic manifestations, suggestive of a genetic defect, array comparative genomic hybridization…

Pathologymedicine.medical_specialtyChromosomes Human Pair 22IrritabilityMeaslesRubellaDiGeorge syndromeAcute disseminated encephalomyelitismedicineDiGeorge SyndromeHumansComparative Genomic HybridizationADEM; DiGeorge syndromeGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryEncephalomyelitis Acute DisseminatedVaccinationPublic Health Environmental and Occupational HealthBrainInfantmedicine.diseaseRashDermatologyMagnetic Resonance ImagingVaccinationInfectious Diseasesmedicine.anatomical_structureAcute disseminated encephalomyelitisMolecular MedicineFemaleEyelidmedicine.symptombusinessMeasles-Mumps-Rubella Vaccine
researchProduct